The White House deal will see Regeneron offer all its new medicines at “MFN prices”, while providing Otarmeni for free to ...
The U.S. Food and Drug Administration has given accelerated approval for Regeneron's Otarmeni gene therapy, which Trump says ...
Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under ...
President Donald Trump will be announcing a drug pricing deal with Regeneron at the White House on Thursday at 3 p.m., ...
President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products ...
Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump ...
The White House will announce a drug pricing deal with Regeneron Pharmaceuticals on Thursday, according to a source familiar ...
Regeneron is the latest pharmaceutical manufacturer to make a deal with the administration to offer some of their drugs at ...
With Regeneron poised to announce a drug pricing deal with the White House Thursday, all 17 companies targeted in a round of ...
Of the 17 companies that were implored by the White House last July to apply Most Favored Nation pricing to their drugs, ...
The White House is set to announce a drug pricing agreement with Regeneron Pharmaceuticals, the only major drugmaker among 17 contacted by President Trump in July, to finalize such a deal. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results